October 26, 2014 12:00 AM ET

Pharmaceuticals

Company Overview of UCB Pharma GmbH

Company Overview

UCB Pharma GmbH develops, commercializes, and researches pharmaceutical and biotechnological products. It develops novel medicines in the therapeutic areas of the central nervous system. The company was formerly known as Schwartz Pharma AG and changed its name to UCB Pharma GmbH in May 2009.UCB Pharma GmbH was founded in 1946 and is based in Monheim, Germany. UCB Pharma GmbH operates as a subsidiary of UCB SA.

Alfred-Nobel-Strasse 10

Monheim,  40789

Germany

Founded in 1946

Phone:

49 2173 48 4848

Fax:

49 2173 48 4841

Key Executives for UCB Pharma GmbH

General Manager and Managing Director
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Lohmann Animal Health GmbH & Co. KG Europe
Biotie Therapies GmbH Europe
Heidelberg Pharma GmbH Europe
BREMER PHARMA GmbH Europe
ANIMEDICA Group GmbH Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UCB Pharma GmbH, please visit www.ucb.de. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.